Nanostream Recruits Top Talent to Support Rapid Expansion of Customer Base
News Oct 21, 2005
Nanostream has announced that Dr. Thomas J. Onofrey has joined Nanostream as director of applications development.
He brings over 10 years of experience in developing application techniques and managing research efforts in areas such as biomolecular immobilization, detection systems and assay design.
As director of applications development, Dr. Onofrey will be responsible for driving the development of analytical applications across drug discovery for Nanostream's micro parallel liquid chromatography (PLC) products.
Also, Dr. Onofrey will oversee sample projects for prospective customers and present experiment results to them.
A critical function of his role will be gathering input from customers to provide recommendations regarding enhancements and features to Nanostream products.
“Tom's deep knowledge of assay design and development will be invaluable to our customers,” said Stephen D. O'Connor, CEO of Nanostream.
“He is helping Nanostream's customers use our product to develop assays faster and to achieve higher data quality than they can get using other technologies.”
Dr. Onofrey has a track record of innovative work with liquid chromatography instrumentation for applications such as ADME assays, biomolecular immobilization and natural product synthesis.
Prior to working at Nanostream, Dr. Onofrey served as manager of R&D at Millipore, Inc., where he developed filter-based ADME assays using Millipore's membrane technology.
As a group leader of R&D for Nanogen, he developed immobilization DNA technology for Nanogen's molecular biology workstation.
He completed his post-doctoral program at the University of California at Irvine in synthetic methodology and natural product synthesis.
Dr. Onofrey received a BA in chemistry from the College of the Holy Cross in 1989 and his PhD in organic chemistry from Dartmouth College in 1996. He has authored over 25 publications and posters in addition to holding numerous patents.
“At Nanostream, we collaborate with our customers every day to develop new applications and to expand our product portfolio,” said Dr. Onofrey.
“Our innovative and multidisciplinary team is poised to achieve some incredible results. We need to grow to continue to deliver excellent service as our customer base expands, and we are looking for enthusiastic candidates who are ready for the never-ending challenges and rewards of working at Nanostream.”
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018